A single injection of a protein called FGF1 is enough to restore blood sugar levels to a healthy range, and long-term use can reverse insulin insensitivity, in rats with diet-induced diabetes, a new study shows.
“Controlling glucose is a dominant problem in our society,” says Ronald M. Evans, director of Salk Institute’s Gene Expression Laboratory one of the authors of a new paper on the study. “And FGF1 offers a new method to control glucose in a powerful and unexpected way.”
The two-fold improvement in the equivalent of type 2 diabetes in the mice was dramatic, the scientists said. And it also came without the side effects common to most diabetes treatments.
Almost 30 million people in the United States are estimated to have type 2 diabetes, much of it brought on my excess weight and inactivity. More about the report is available at Medical News Today.
Here is a video about the study from the Salk Institute, featuring some of the researchers involved:
For more information about current research studies with Discovery Clinical Trials, please visit our website by clicking on the image:
